Login to Your Account

Other News To Note

Monday, March 28, 2011
Boehringer Ingelheim GmbH, of Ingelheim, Germany, acquired a biopharmaceutical development and manufacturing facility in Fremont, Calif., from Amgen Inc., of Thousand Oaks, Calif. The facility contains more than 200,000 square feet of laboratory space and employs more than 300 people.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription